Overview

Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
A Phase 2, Randomized, Controlled Evaluation of the Efficacy and Safety of HTX-011 or HTX-002 for Post-Operative Analgesia Following Abdominoplasty Surgery
Phase:
Phase 2
Details
Lead Sponsor:
Heron Therapeutics
Treatments:
Bupivacaine